FTI
84
2
V
72
-4
NTAP
73
6
WU
34
-2
WAT
64
7
F
54
-6
HCA
48
2
CVX
46
8
TAP
63
2
GME
70
2
CTSH
60
3
EMC
56
-3
GE
72
4
SWKS
51
-2
URI
73
5
RL
80
2
PNW
70
3
PSA
63
2
NAVI
52
-3
PCG
93
4
FTI
84
2
V
72
-4
NTAP
73
6
WU
34
-2
WAT
64
7
F
54
-6
HCA
48
2
CVX
46
8
TAP
63
2
GME
70
2
CTSH
60
3
EMC
56
-3
GE
72
4
SWKS
51
-2
URI
73
5
RL
80
2
PNW
70
3
PSA
63
2
NAVI
52
-3
PCG
93
4
Financhill
Back

Foxx Development Holdings Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
35

FOXX
Foxx Development Holdings

Last Price:
4.99
Seasonality Move:
--
Sell
49

SRPT
Sarepta Therapeutics

Last Price:
135.64
Seasonality Move:
14.88%
Sell
35
Foxx Development Holdings (FOXX) is a Sell

Is Foxx Development Holdings a Buy, Sell or Hold?

  • The current Foxx Development Holdings [FOXX] share price is $5.90. The Score for FOXX is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • FOXX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $130.50. The Score for SRPT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FOXX Stock Price Chart

What is Foxx Development Holdings's stock price today?

  • The Foxx Development Holdings share price today is $5.90
    The current trend is relatively stagnant and FOXX is experiencing selling pressure, which indicates risk of future bearish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $130.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

FOXX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.25 Sell
Relative Strength Index (14 RSI): 35.56 Sell
Chaikin Money Flow: -35242 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (6.36 - 8.12) Sell
Bollinger Bands (100): ( - ) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.3 Sell
Relative Strength Index (14 RSI): 64.59 Buy
Chaikin Money Flow: 3149400 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.02 - 128.88) Buy
Bollinger Bands (100): (119.18 - 142.3) Sell

FOXX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.33 Sell
20-day SMA: 6.98 Sell
50-day SMA: 0 Buy
200-day SMA: 0 Buy
8-day EMA: 6.23 Sell
20-day EMA: 6.73 Sell
50-day EMA: 5.92 Sell
200-day EMA: 2.55 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 112.07 Buy
20-day SMA: 117.27 Buy
50-day SMA: 121.92 Buy
200-day SMA: 129.99 Buy
8-day EMA: 116.28 Buy
20-day EMA: 117.14 Buy
50-day EMA: 121.91 Buy
200-day EMA: 125.98 Buy

Foxx Development Holdings Earnings Growth & FOXX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.87 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.76 per share.

Foxx Development Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):